Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page
- Check2 days agoChange DetectedAdds the Contacts/Locations and Study Status sections to the version history, improving access to study contact details and the current trial status. Introduces revision v3.6.4 for version 50 on 2026-07-17 and removes the prior v3.6.3 revision on 2026-04-23.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe revision tag on the page updates from v3.6.2 to v3.6.3, indicating a new release version of the page. This typically reflects a minor update to the site's underlying system rather than changes to the page content.SummaryDifference0.1%

- Check31 days agoChange DetectedFooter shows Revision: v3.6.2, replacing v3.6.0, indicating a new build of the ClinicalTrials.gov interface. The change does not modify the study history data or how the page operates.SummaryDifference0.1%

- Check45 days agoChange DetectedRecruitment status has been updated to 'no longer looking for participants,' indicating the trial is no longer actively seeking enrollees. The revision history also shows a new release labeled v3.6.0 and the prior v3.5.5 entry has been removed from the log.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page history shows a new Revision: v3.5.5 replacing the previous v3.5.4, reflecting an update to the record history interface.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision label v3.5.4 was added and the previous v3.5.3 revision was removed from the page history.SummaryDifference0.1%

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.